These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32358836)

  • 1. Cost-effectiveness evaluation of the PROPPR trial transfusion protocols.
    Callcut RA; Simpson KN; Baraniuk S; Fox EE; Tilley BC; Holcomb JB;
    Transfusion; 2020 May; 60(5):922-931. PubMed ID: 32358836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial: design, rationale and implementation.
    Baraniuk S; Tilley BC; del Junco DJ; Fox EE; van Belle G; Wade CE; Podbielski JM; Beeler AM; Hess JR; Bulger EM; Schreiber MA; Inaba K; Fabian TC; Kerby JD; Cohen MJ; Miller CN; Rizoli S; Scalea TM; O'Keeffe T; Brasel KJ; Cotton BA; Muskat P; Holcomb JB;
    Injury; 2014 Sep; 45(9):1287-95. PubMed ID: 24996573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-based differences in transfusion need after severe injury: Findings of the PROPPR study.
    McCrum ML; Leroux B; Fang T; Bulger E; Arbabi S; Wade CE; Fox E; Holcomb JB; Robinson B;
    Surgery; 2019 Jun; 165(6):1122-1127. PubMed ID: 30871812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pragmatic randomized optimal platelet and plasma ratios trial: what does it mean for remote damage control resuscitation?
    Yonge JD; Schreiber MA
    Transfusion; 2016 Apr; 56 Suppl 2():S149-56. PubMed ID: 27100751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of uncross-matched blood transfusion on the need for massive transfusion and mortality: analysis of 5,166 uncross-matched units.
    Inaba K; Teixeira PG; Shulman I; Nelson J; Lee J; Salim A; Brown C; Demetriades D; Rhee P
    J Trauma; 2008 Dec; 65(6):1222-6. PubMed ID: 19077605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a massive transfusion protocol for hemorrhagic trauma resuscitation.
    Lim G; Harper-Kirksey K; Parekh R; Manini AF
    Am J Emerg Med; 2018 Jul; 36(7):1178-1181. PubMed ID: 29208320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal Dose, Timing and Ratio of Blood Products in Massive Transfusion: Results from a Systematic Review.
    McQuilten ZK; Crighton G; Brunskill S; Morison JK; Richter TH; Waters N; Murphy MF; Wood EM
    Transfus Med Rev; 2018 Jan; 32(1):6-15. PubMed ID: 28803752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic impact of transfusion ratios on outcomes in severely injured patients: Targeted machine learning analysis of the Pragmatic, Randomized Optimal Platelet and Plasma Ratios randomized clinical trial.
    Nguyen M; Pirracchio R; Kornblith LZ; Callcut R; Fox EE; Wade CE; Schreiber M; Holcomb JB; Coyle J; Cohen M; Hubbard A
    J Trauma Acute Care Surg; 2020 Sep; 89(3):505-513. PubMed ID: 32520897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial.
    Holcomb JB; Tilley BC; Baraniuk S; Fox EE; Wade CE; Podbielski JM; del Junco DJ; Brasel KJ; Bulger EM; Callcut RA; Cohen MJ; Cotton BA; Fabian TC; Inaba K; Kerby JD; Muskat P; O'Keeffe T; Rizoli S; Robinson BR; Scalea TM; Schreiber MA; Stein DM; Weinberg JA; Callum JL; Hess JR; Matijevic N; Miller CN; Pittet JF; Hoyt DB; Pearson GD; Leroux B; van Belle G;
    JAMA; 2015 Feb; 313(5):471-82. PubMed ID: 25647203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accounting for differences in transfusion volume: Are all massive transfusions created equal?
    Sharpe JP; Weinberg JA; Magnotti LJ; Maclennan PA; Schroeppel TJ; Fabian TC; Croce MA
    J Trauma Acute Care Surg; 2012 Jun; 72(6):1536-40. PubMed ID: 22695418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Debunking the survival bias myth: characterization of mortality during the initial 24 hours for patients requiring massive transfusion.
    Brown JB; Cohen MJ; Minei JP; Maier RV; West MA; Billiar TR; Peitzman AB; Moore EE; Cushieri J; Sperry JL;
    J Trauma Acute Care Surg; 2012 Aug; 73(2):358-64; discussion 364. PubMed ID: 22846940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High ratio plasma resuscitation does not improve survival in pediatric trauma patients.
    Cannon JW; Johnson MA; Caskey RC; Borgman MA; Neff LP
    J Trauma Acute Care Surg; 2017 Aug; 83(2):211-217. PubMed ID: 28481839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Bayesian Statistics to Reanalyze Data From the Pragmatic Randomized Optimal Platelet and Plasma Ratios Trial.
    Lammers D; Richman J; Holcomb JB; Jansen JO
    JAMA Netw Open; 2023 Feb; 6(2):e230421. PubMed ID: 36811858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing protocol adherence in a clinical trial with ordered treatment regimens: Quantifying the pragmatic, randomized optimal platelet and plasma ratios (PROPPR) trial experience.
    Zhu H; Fox EE; Baraniuk S; Holcomb JB; Wade CE; Del Junco DJ; Tilley BC;
    Injury; 2016 Oct; 47(10):2131-2137. PubMed ID: 27476886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet to erythrocyte transfusion ratio and mortality in massively transfused trauma patients. A systematic review and meta-analysis.
    Rijnhout TWH; Duijst J; Noorman F; Zoodsma M; van Waes OJF; Verhofstad MHJ; Hoencamp R
    J Trauma Acute Care Surg; 2021 Oct; 91(4):759-771. PubMed ID: 34225351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer simulation of transfusion with different blood product ratios in modern massive transfusion protocols.
    Ho AM; Ho AK; Mizubuti GB
    Med Hypotheses; 2019 Apr; 125():10-15. PubMed ID: 30902133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks.
    Holcomb JB; del Junco DJ; Fox EE; Wade CE; Cohen MJ; Schreiber MA; Alarcon LH; Bai Y; Brasel KJ; Bulger EM; Cotton BA; Matijevic N; Muskat P; Myers JG; Phelan HA; White CE; Zhang J; Rahbar MH;
    JAMA Surg; 2013 Feb; 148(2):127-36. PubMed ID: 23560283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of a pediatric trauma massive transfusion protocol: one institution's experience.
    Hendrickson JE; Shaz BH; Pereira G; Parker PM; Jessup P; Atwell F; Polstra B; Atkins E; Johnson KK; Bao G; Easley KA; Josephson CD
    Transfusion; 2012 Jun; 52(6):1228-36. PubMed ID: 22128884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-year analysis of transfusion in Operation Iraqi Freedom and Operation Enduring Freedom: increased plasma and platelet use correlates with improved survival.
    Pidcoke HF; Aden JK; Mora AG; Borgman MA; Spinella PC; Dubick MA; Blackbourne LH; Cap AP
    J Trauma Acute Care Surg; 2012 Dec; 73(6 Suppl 5):S445-52. PubMed ID: 23192068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased platelet:RBC ratios are associated with improved survival after massive transfusion.
    Holcomb JB; Zarzabal LA; Michalek JE; Kozar RA; Spinella PC; Perkins JG; Matijevic N; Dong JF; Pati S; Wade CE; ; Holcomb JB; Wade CE; Cotton BA; Kozar RA; Brasel KJ; Vercruysse GA; MacLeod JB; Dutton RP; Hess JR; Duchesne JC; McSwain NE; Muskat PC; Johannigamn JA; Cryer HM; Tillou A; Cohen MJ; Pittet JF; Knudson P; DeMoya MA; Schreiber MA; Tieu BH; Brundage SI; Napolitano LM; Brunsvold ME; Sihler KC; Beilman GJ; Peitzman AB; Zenati MS; Sperry JL; Alarcon LH; Croce MA; Minei JP; Steward RM; Cohn SM; Michalek JE; Bulger EM; Nunez TC; Ivatury RR; Meredith JW; Miller PR; Pomper GJ; Marin B
    J Trauma; 2011 Aug; 71(2 Suppl 3):S318-28. PubMed ID: 21814099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.